Abstract:Endogenous adenosine can protect the overloaded heart against the development of hypertrophy and heart failure, but the contribution of A 1 receptors (A 1 R) and A 3 receptors(A 3 R) is not known. To test the hypothesis A 1 R and A 3 R can protect the heart against systolic overload, we exposed A 3 R gene deficient (A 3 R KO) mice and A 1 R KO mice to transverse aortic constriction (TAC). Contrary to our hypothesis, A 3 R KO attenuated 5 weeks TAC-induced left ventricular (LV) hypertrophy (ratio of ventricular mass/body weight increased to 7.6 ±0.3 mg/g in wild type (Wt) mice as compared with 6.3±0.4 mg/g in KO), fibrosis and dysfunction (LV ejection fraction decreased to 43±2.5% and 55±4.2% in Wt and KO mice, respectively). A 3 R KO also attenuated the TAC-induced increases of myocardial ANP and the oxidative stress markers 3-nitrotyrosine(3-NT ) and 4-hydroxynonenal. In addition, A 3 R KO significantly attenuated TAC-induced activation of multiple MAP kinase pathways, and the activation of Akt-GSK signaling pathway. In contrast, A 1 R-KO increased TAC-induced mortality, but did not alter ventricular hypertrophy or dysfunction compared to Wt mice. In mice in which extracellular adenosine production was impaired by CD73 KO, TAC caused greater hypertrophy and dysfunction, and increased myocardial 3-NT, indicates that extracellular adenosine protects heart against TAC-induced ventricular oxidative stress and hypertrophy. In neonatal rat cardiomyocytes induced to hypertrophy with phenylephrine, the adenosine analogue 2-chloroadenosine (CADO) reduced cell area, protein synthesis, ANP and 3-NT. Antagonism of A3R significantly potentiated the anti-hypertrophic effects of CADO. Our data demonstrated that extracellular adenosine exerts protective effects on the overloaded heart, but A 3 R act counter to the protective effect of adenosine. The data suggest that selective attenuation of A 3 R activity might be a novel approach to attenuate pressure overload-induced myocardial oxidative stress, LV hypertrophy and dysfunction. This research has received full or partial funding support from the American Heart Association, AHA Midwest Affiliate (Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, South Dakota & Wisconsin).

Adenosine Kinase Regulation of Cardiomyocyte Hypertrophy

Abstract 21116: Adenosine Kinase Regulation of Cardiomyocyte Hypertrophy

A2B Adenosine Receptor-Mediated Induction of IL-6 Promotes CKD.

Adenosine Kinase Attenuates Cardiomyocyte Microtubule Stabilization and Protects Against Pressure Overload-Induced Hypertrophy and LV Dysfunction.

Adenosine Regulation of Microtubule Dynamics in Cardiac Hypertrophy.

[Adenosine Protects Cardiomyocytes from Hypoxia/reoxygenation Injury].

GW24-e2121 Adenosine Monophosphate-Activated Protein Kinase Attenuates Cardiomyocyte Hypertrophy Through Regulation of FOXO3a/MAFbx Signalling Pathway

Activation of AMPK Inhibits Cardiomyocyte Hypertrophy by Modulating of the FOXO1/MuRF1 Signaling Pathway in Vitro

Long-Term Activation of Adenosine Monophosphate-Activated Protein Kinase Attenuates Pressure-Overload-Induced Cardiac Hypertrophy

Abstract 17221: AMPK Regulation of Microtubule Dynamics in Cardiac Hypertrophy

Adenosine Kinase Inhibition Augments Conducted Vasodilation and Prevents Left Ventricle Diastolic Dysfunction in Heart Failure with Preserved Ejection Fraction.

Adenosine Kinase Inhibition Enhances Microvascular Dilator Function and Improves Left Ventricle Diastolic Dysfunction

Abstract 1582: Adenosine A3 Receptor Deficiency Exerts Unanticipated Protective Effects on Pressure Overloaded-Induced Left Ventricular Hypertrophy and Dysfunction in Mice

An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.

Accumulation of endogenous adenosine improves cardiomyocyte metabolism via epigenetic reprogramming in an ischemia-reperfusion model

AMPK Attenuates Microtubule Proliferation in Cardiac Hypertrophy.

Molecular Mechanism Underlying Adenosine Receptor-Mediated Mitochondrial Targeting of Protein Kinase C

Protein Kinase A and Protein Kinase C Synergistically Activate theRaf-1 Kinase/Mitogen-activated Protein Kinase Cascade in Neonatal Rat Cardiomyocytes

Adenosine A1 receptor activation reduces opening of mitochondrial permeability transition pores in hypoxic cardiomyocytes.

Role of Protein Kinase C in Adenosine A1 Receptor Regulating Opening of Mitochondria Permeability Transition Pore in Hypoxic Cardiac Myocytes

Cell-signaling Evidence for Adenosine Stimulation of Coronary Smooth Muscle Proliferation Via the A1 Adenosine Receptor.